MedTrace Logo

CUHK Brain Health Longitudinal Study

NCT03592563 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2026-02-24

No results posted yet for this study

Summary

The goal of this study is to develop a large longitudinal cohort of individuals diagnosed with or at high risk for brain diseases (both neurological and psychiatric in nature), in order to identify risk factors that contribute to neurological and psychiatric diseases over time. The investigators seek to capture relevant information from medical records, electronically administered questionnaires and follow up phone-based interviews. The investigators expect to eventually have sufficient power from our dataset to examine risk factors for a variety of brain disorders, both individually and in aggregate. Our ultimate goal is to offer scientifically validated ways to preserve and promote brain health by working with our patients' needs and tracking their progress over time.

Conditions

  • Stroke, Ischemic
  • Stroke Syndrome
  • Stroke
  • Stroke, Acute
  • Dementia
  • Brain Ischemia
  • Brain Diseases
  • Alzheimer Disease
  • Health Attitude
  • Health Knowledge, Attitudes, Practice
  • Health Personnel Attitude
  • Healthy Aging

Interventions

BEHAVIORAL

Neuro-QoL questionnaire

Follow-up over time will continue (either in-person or over the phone) using the same questionnaires (depending on which group they are belongs to) at approximately 6-month intervals. During each follow-up, participants will be screened for any new signs, symptoms and diagnoses of neurological and/or psychiatric disorders, in order to correlate these outcomes with risk factors captured using the procedures described above.

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Thomas Wai Hong LEUNG, FRCP · Division of Neurology, The Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2038-12-31
Completion
2048-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03592563 on ClinicalTrials.gov